2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1316005853 M.D.
Verify on CMS →

INDIRA KAILAS, M.D.

Addiction Medicine (Psychiatry & Neurology) Physician in MARRERO, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 115 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$489.74
26 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

INDIRA KAILAS, M.D. filed 1,991 Medicare Part D claims in 2023 as a Addiction Medicine (Psychiatry & Neurology) Physician in MARRERO, Louisiana, prescribing 91% generic.

2K
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

INDIRA KAILAS, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,991 Top 16% higher than 84% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). This entry sits in this band. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

INDIRA KAILAS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about INDIRA KAILAS, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/05/2006

NPI 1316005853

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

1,991 95% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

Specialty distribution in Louisiana

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Louisiana providers

Louisiana providers

Addiction Medicine (Psychiatry & Neurology) Physician share within Louisiana

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within Louisiana

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

INDIRA KAILAS, M.D. appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at 5001 WESTBANK EXPRESSWAY, MARRERO, LA, 70072, with a listed phone of (504) 349-8708. NPI 1316005853 was issued on 12/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KAILAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,991 prescription claims written by this provider, covering 115 Medicare beneficiaries and totaling roughly $512K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5001 WESTBANK EXPRESSWAY
MARRERO, LA 70072

Provider Details

NPI 1316005853
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Credentials M.D.
Gender Female
NPI Issued 12/05/2006

Hospital and facility affiliations

Facilities where INDIRA KAILAS, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JEFFCARE
METAIRIE, LA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for INDIRA KAILAS, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$490

Largest payer

Lundbeck LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

INDIRA KAILAS, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 1,991 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,991
Total Claims
$512K
Total Drug Cost
115
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,220
Total Day Supply
65,126
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$423K
Generic Drug Cost
$89K

Patient Demographics

Average Patient Age
54.1 years
Avg HCC Risk Score
1.21
Gender Split
55% female / 45% male
Age Distribution
<65: 81, 65-74: 30, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What INDIRA KAILAS, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Sertraline Hcl
145
Quetiapine Fumarate
125
Buspirone Hcl
119
Trazodone Hcl
119
Risperidone
116
Fluoxetine Hcl
85
Benztropine Mesylate
82
Mirtazapine
60
Citalopram Hbr
Citalopram Hydrobromide
57
Divalproex Sodium Er
Divalproex Sodium
54

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How INDIRA KAILAS, M.D. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

INDIRA KAILAS, M.D.'s 1,991 claims are above the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Louisiana

Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as KAILAS.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is INDIRA KAILAS, M.D.'s specialty?
INDIRA KAILAS, M.D. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in MARRERO, Louisiana. Credentials: M.D..
How much does INDIRA KAILAS, M.D. prescribe under Medicare Part D?
In 2023, INDIRA KAILAS, M.D. wrote 1,991 Medicare Part D claims totaling $512K in drug costs for 115 beneficiaries.
Where is INDIRA KAILAS, M.D. located?
INDIRA KAILAS, M.D. is located at 5001 WESTBANK EXPRESSWAY, MARRERO, LA, 70072. Phone: (504) 349-8708.
What is INDIRA KAILAS, M.D.'s NPI number?
INDIRA KAILAS, M.D.'s National Provider Identifier (NPI) is 1316005853, issued on 12/05/2006.
Does INDIRA KAILAS, M.D. prescribe more brand-name or generic drugs?
INDIRA KAILAS, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $423K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does INDIRA KAILAS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, INDIRA KAILAS, M.D.'s most frequently prescribed drugs include Sertraline Hcl, Quetiapine Fumarate, Buspirone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does INDIRA KAILAS, M.D. accept Medicare?
INDIRA KAILAS, M.D. appears in CMS Medicare data with 1,991 Part D claims and 115 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify INDIRA KAILAS, M.D.'s credentials?
INDIRA KAILAS, M.D.'s NPI is 1316005853 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology